期刊文献+

宫颈鳞状细胞癌对DDP和DDP+5-FU的体外药敏检测及与耐药蛋白表达的关系研究 被引量:1

In vitro drug sensitivity test for cervical squamous cell carcinoma to DDP and DDP+5-FU and the correlation with drug resistance protein expression
下载PDF
导出
摘要 目的通过对宫颈鳞状细胞癌进行顺铂(DDP)和DDP+5-氟尿嘧啶(5-FU)体外药敏检测,比较两种化疗方案的体外有效率。同时检测其耐药蛋白P糖蛋白(P-gp)、谷胱甘肽S-转移酶-π(GST-π)、DNA拓扑异构酶Ⅱ(TopoⅡ)、胸苷酸合成酶(TS)的表达,探讨DDP和DDP+5-FU体外药敏与耐药蛋白表达的关系。方法收集35例宫颈鳞状细胞癌患者的新鲜肿瘤组织,采用三磷酸腺苷生物荧光法(ATP-TCA)对DDP和DDP+5-FU进行体外药敏检测,同时采用EnVision二步法检测宫颈鳞状细胞癌组织中耐药蛋白P-gp、GST-π、TopoⅡ、TS的表达,并分析DDP和DDP+5-FU的体外药敏与耐药蛋白P-gp、GST-π、TopoⅡ、TS表达的关系。结果 35例标本均进行药敏试验,DDP的体外有效率为37.14%,与DDP+5-FU的51.43%比较,差异无统计学意义(P> 0.05)。经多因素分析发现,患者年龄、临床分期、分化程度均不为DDP、DDP+5-FU药物敏感性的影响因素(P> 0.05)。P-gp、GST-π、TopoⅡ、TS蛋白阳性表达率分别为57.14%(20/35)、51.43%(18/35)、71.43%(25/35)、57.14%(20/35)。GST-π蛋白阳性表达是宫颈鳞状细胞癌对DDP耐药的影响因素(P=0.002);TS蛋白阳性表达是宫颈鳞状细胞癌对DDP+5-FU耐药的影响因素(P=0.001)。结论 宫颈鳞状细胞癌ATP-TCA法检测DDP+5-FU与单药DDP相比,体外有效率无显著差异。GST-π、TS蛋白阳性表达可用于临床宫颈癌患者对DDP、5-FU化疗耐药的预测指标。 Objective To determine the in vitro drug sensitivity of cervical squamous cell carcinoma(SCC) to cisplatin(DDP) and cisplatin plus 5-fluorouracil(DDP+5-FU) to compare the in vitro efficacy of the two regimens,and to detect the expression of P-glycoprotein(P-gp),glutathione S-transferase-π(GST-π),topoisomerases Ⅱ(topoll),and thymidylate synthase(TS) expression.Method Fresh tumor tissues were collected from 35 patients with cervical SCC,in which the drug sensitivity to DDP and DDP+5-FU was detected in vitro by triphosadenine bioluminescence assay(ATPTCA),at the same time,EnVision,the two-step detection system,was employed to detect the expression of drug resistance proteins including P-gp,GST-π,topoll,and TS.Furthermore,the relationship between the in vitro sensitivity of DDP and DDP+5-FU and drug resistance proteins P-gp,GST-π,topoll,and TS was assessed.Result ATP-TCA drug sensitivity test was performed on 35 cervical SCC specimens,indicating an in vitro response rate to DDP of 37.14%,which was numerically lower than that of DDP+5-FU at 51.43%,but there was no significant difference(P>0.05).Multivariate analysis revealed that,age,clinical stage,differentiation degree were not factors influencing the drug sensitivity of DDP,DDP+5-FU(P>0.05).The positive expression rate of P-gp,GST-π,topoll,and TS proteins were 57.14%(20/35),51.43%(18/35),71.43%(25/35),and 57.14%(20/35),respectively.Positive expression of GST-π protein was correlated with drug resistance of cervical SCC cells to DDP(P=0.002);meanwhile,TS protein expression was similarly related to drug resistance to DDP+5-FU of cervical SCC cells(P=0.001).Conclusion No significant difference regarding the in vitro efficacy of DDP+5-FU versus DDP alone was demonstrated by ATP-TCA assay.Positive expression of GST-π and TS proteins are potentially predictive for the chemoresistance cervical cancer patients to DDP,5-FU.
作者 苏丰丽 孔为民 刘志茹 宋丹 卞丽红 SU Fengli;KONG Weimin;LIU Zhiru;SONG Dan;BIAN Lihong(Department of Gynecologic Oncology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100006,China;Department of Gynecology,Amcare Women and Children Hospital,Beijing 100015,China;Department of Gynecology,the Fifth Medical Center of PLA General Hospital,Beijing 100071,China)
出处 《癌症进展》 2020年第4期351-355,共5页 Oncology Progress
基金 北京市科学技术委员会首都市民健康项目培育课题(Z151100003915149)。
关键词 三磷酸腺苷生物荧光法 P糖蛋白 谷胱甘肽S-转移酶 DNA拓扑异构酶 胸苷酸合成酶 ATP-TCA P-glycoprotein glutathione S-transferase topoisomerases thymidylate synthase
  • 相关文献

参考文献1

二级参考文献14

  • 1田海梅,石晓燕,傅军,曹冬艳,张凯,吴令英,王金万,张伟.ATP抗肿瘤药物敏感性检测技术与卵巢癌临床治疗的相关性研究[J].中华肿瘤杂志,2005,27(5):296-298. 被引量:17
  • 2梁智,田海梅,李艳芬,曹冬艳,刘毅,李茉,王小兵,程冬婉,张伟.胶滴肿瘤药敏检测技术(CD-DST)的建立及初步临床应用研究[J].癌症进展,2006,4(6):545-549. 被引量:11
  • 3高国兰,万红英,邹学森,陈文学,陈岳青,黄秀珍.子宫颈癌组织三磷酸腺苷肿瘤体外药物敏感试验及其与耐药蛋白表达的关系[J].中华妇产科杂志,2007,42(3):201-205. 被引量:9
  • 4丰有吉,主编.妇产科学[M].北京:人民卫生出版社.2007:322-324.
  • 5Inaba M, Tashiro T, Sato S,et al. In vitro-in vivo correlation inanticancer drug sensitivity test using AUC-based concentrationsand collagen gel droplet-embedded culture[J]. Oncology,1996,53(3)=250-257.
  • 6Takamura Y,Kobayashi H, Taguchi T, et al. Prediction of che-motherapeutic response by collagen gel droplet embedded cul-ture-drug sensitivity test in human breast cancers[J]. Int J Canc-er,2002,98(3) =450-455.
  • 7Yabushita H,Ohnishi M,Komiyama M, et al. Usefulness of col-lagen gel droplet embedded culture drug sensitivity testing in o-varian cancerQ]. Oncol Rep,2004,12(2) : 307-311.
  • 8cher CM, Cree I A, Bruckner HW. Use of an ex vivo ATPluminescence assay to direct chemotherapy for recurrent ovariancancer[J]. Anticancer Drugs, 1998?9(1) :51-57.
  • 9Sevin BU, Perras JP, Averette HE, et al. Chemosensitivity tes-ting in ovarian cancer[J]. Cancer, 1993?71(4) : 1613-1620.
  • 10Sevin BU, Peng ZL, Perras JP, et al. Application of all ATP bi-oluminescence assay in human tumor chemosensitivity testing[J]. Gynecol Oncol,1988,31(l) :191-204.

共引文献2

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部